Purpose
The role of image-guided percutaneous hepatic biopsy as a safe and accurate diagnostic procedure for the evaluation of focal or diffuse hepatic disease has been well established, especially with the advent of spring-loaded biopsy needles and improvements in image quality (1) . US and CT guidance are the techniques of choice for liver biopsy. In comparison with CT, US is often more readily available. US-guided biopsies may be easier to perform, faster, and less expensive and do not expose the patient to radiation (2) .
Most of the studies concerning the safety and efficacy of liver needle biopsies have been performed in patients with diffuse liver disease rather than focal liver lesions (3, 4) . Many of the core liver biopsies performed at our institution are for focal lesions. The number of biopsy passes is usually determined by the radiologist performing the biopsy by consulting results of an on-site cytologic evaluation (performed by a cytologist or cytotechnologist), on the basis of findings from a rapid touch preparation smear of the core. This on-site cytologic evaluation guides the radiologist to continue to another biopsy pass and avoid a nondiagnostic biopsy result on one hand and potentially reduces the rate of repeat biopsies on the other hand. However, the service of an on-site cytologist is not always available.
The aim of this study was to evaluate efficacy and safety of percutaneous liver biopsy performed with 18G automatic needles under the assistance of ultrasonography in focal hepatic lesions and share our clinical experiences.
Methods and Materials
We performed percutaneous biopsies in the 38 patient's liver masses with ultrasoundassisted free-hand technique in last one year. The liver biopsies were per-formed following one-night fasting using 18G automatic needles. After the biopsies, all patients were hospitalized and monitored for one day. All specimens were examined without immediate assessment by a pathologist. 
Results
A total of 38 hepatic masses from 38 patients were biopsied in last one year (female: 16 (42,1%), male: 22 (57,9%); mean age: 48,9 years). Of 38 biopsies, 35 (%92,1) specimens were considered diagnostic and 3 (%7,9) speci-mens were considered as non-diagnostic. Hepatic mass sizes varied between 14 mm and 155, with a mean diameter of 42± 27 mm. No major complication was seen.
Conclusion
According to our experiences, we conclude that ultrasound assisted percutaneous liver mass biopsy with 18 G automatic needles is a quick, effective, minimally invasive and, safe procedure. The complication rate is very low. The ultrasound assisted percutaneous liver mass biopsy modality should be used in all cases that the lesion can be visualized by ultrasonography.
